Results 251 to 260 of about 2,190,614 (293)

Brain and Liver Dual‐Targeting Oridonin Nanoparticles to Enhance Aβ Clearance for Alzheimer's Disease Therapy

open access: yesAdvanced Science, EarlyView.
We developed a nanoparticle named OAF, which simultaneously targeted to both the brain and liver via the transferrin receptor 1 (TfR1) receptor, promoting lipoprotein receptor‐related protein 1 (LRP1) expression to enhance amyloid‐beta (Aβ) clearance. In AD mice model, OAF significantly reduced Aβ deposition and cognitive impairment, while a mitigating
Wenshuai Gong   +8 more
wiley   +1 more source

Alzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone

open access: yesAdvanced Science, EarlyView.
In aging bone, osteocytes accumulate neurodegenerative risk factor Apolipoprotein E (APOE). A humanized version of the Alzheimer's disease risk allele APOE4 altered the mouse bone transcriptome and proteome, with effects in female bone surpassing the brain, including bone fragility due to suppressed osteocytic maintenance of bone quality, identifying ...
Charles A. Schurman   +15 more
wiley   +1 more source

Microglia‐Targeted Biomimetic Tetrahedral Framework Nucleic Acid Nanovesicles for Synergistic Treatment of Sepsis‐Associated Encephalopathy

open access: yesAdvanced Science, EarlyView.
Sepsis‐associated encephalopathy (SAE) lacks effective therapies. We developed ME@FDsi, a biomimetic nanodrug using a tetrahedral framework nucleic acid to deliver disulfiram and siTNFα. It crosses the blood‐brain barrier, targets M1 microglia, inhibits pyroptosis and inflammation, and scavenges ROS.
Huimin Shi   +15 more
wiley   +1 more source

G4‐Ligand‐Directed PROTACs Unveil DR1 as a Novel Ligand‐Co‐Binding G4‐Protein and Reshape G4‐Dependent Transcription

open access: yesAdvanced Science, EarlyView.
G4‐binding proteins (G4BPs) that specifically co‐bind G4s in the presence of small‐molecule ligands represent a critical but unexplored class of proteins. We introduce G4‐Ligand‐Directed PROTACs (G4L‐TACs), a chemical platform that couples G4 ligands (PDS) to E3 recruiters to selectively degrade these ligand‐co‐binding G4BPs.
Mao‐Lin Li   +8 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Deciphering Protein Corona by scFv-Based Affinity Chromatography.

Nano letters (Print), 2021
It remains challenging to precisely decipher the structural and functional characteristics of protein coronas. To overcome the drawbacks frequently occurring in the traditional separation methods, an anti-PEG single-chain variable fragment (PEG-scFv ...
Yuxiu Chu   +8 more
semanticscholar   +1 more source

Twin-column CaptureSMB: a novel cyclic process for protein A affinity chromatography.

Journal of Chromatography A, 2015
M. Angarita   +5 more
semanticscholar   +3 more sources

Recent advances in bio‐affinity chromatography for screening bioactive compounds from natural products

Journal of Pharmaceutical and Biomedical Analysis, 2019
HighlightsBio‐affinity chromatography (BAC) showed a great potential in natural products screening.An overview of the BAC and its applications for natural products screening was presented.Current reported BAC stationary phases for natural products ...
Jialiang Guo   +5 more
semanticscholar   +1 more source

Applications of aptamer affinity chromatography

TrAC - Trends in Analytical Chemistry, 2012
Qiang Zhao   +3 more
semanticscholar   +3 more sources

affinity chromatography

Catalysis from A to Z, 2020
J. Xu
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy